Valeant Pharmaceuticals International, Inc. (VRX) recently announced that the company has entered into a definitive agreement to acquire all of the outstanding common stock of Obagi Medical Products, Inc. (OMPI) for $19.75 per share …
Valeant said it would buy Obagi Medical Products Inc OMPI.O for about $344 million to boost its dermatology business. Valeant shares closed at C$75.21 and played the biggest role of any single stock in leading the market higher. As a …
It comprises two operational divisions dedicated to serve the pharmaceutical industry: Pharmaceutical Systems with …
Energy minister Mmamaloko Kubayi is off the hook after the parliamentary ... suspension of her department's director-general for policy, planning and clean energy, Ompi Aphane. After being on the parliamentary programme for some …
Collectively, the two own 0.7 percent of outstanding common stock, according to Thomson Reuters data ... its intention to replace the entire board of Obagi Medical Products Inc OMPI.O. Soon after that Obagi said it would be sold to Valeant …
Finweek repeatedly asked for interviews with Energy Minister Dipuo Peters, as well as her deputy director-general in charge of electricity, nuclear and clean energy, Ompi Aphane ... to buy Uranium One shares, the stock has once again …
Vancouver, BC, June 30, 2012 - (ACN Newswire) - Mid-Day Healthcare Stocks Review: Obagi Medical Products, Inc. (NASDAQ:OMPI - News) Shares up and rising $14.94 Up 0.66 (+4.61%) on unusual volume after buy-out rumors …
MONTREAL - Valeant Pharmaceuticals raised its friendly offer to buy Obagi ... an area of which we are very focused." Obagi (Nasdaq:OMPI) said its board of directors unanimously approved the amended offer from Valeant and …